Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Microbiology|February 12, 1998
Virulence factors of Escherichia coli isolates from patients with symptomatic and asymptomatic bacteriuria and neuropathic bladders due to spinal cord and brain injuriesR A Hull, D C Rudy, I E Wieser, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Enantioselective disposition of ibuprofen in elderly persons with and without renal impairmentA C Rudy, P M Knight, D C Brater, et al.
Anesthesia and Analgesia|June 24, 2003
Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteersBarbara A Coda, Anita C Rudy, Sanford M Archer, et al.
Urology|April 1, 1984
Adult respiratory distress syndrome complicating percutaneous nephrolithotripsyD C Rudy, J R Woodside, T A Borden, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 28, 2004
Pharmacokinetics of butorphanol tartrate administered from single-dose intranasal sprayerGeorge A Davis, Anita C Rudy, Sanford M Archer, et al.
Arthritis and Rheumatism|October 8, 1999
Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferiJ Chen, J A Field, L Glickstein, et al.
The Journal of Experimental Medicine|September 1, 1996
An Epstein-Barr virus-associated superantigenN Sutkowski, T Palkama, C Ciurli, et al.
British Journal of Clinical Pharmacology|January 1, 1994
The pharmacokinetics of piroxicam in elderly persons with and without renal impairmentA C Rudy, N L Figueroa, S D Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Stereoselective metabolism of ibuprofen in humans: administration of R-, S- and racemic ibuprofenA C Rudy, P M Knight, D C Brater, et al.
Epilepsy Research|December 3, 2008
A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulationDaniel P Wermeling, Kenneth A Record, Sanford M Archer, et al.
Pageof 15